Testosterone Replacement Therapy Not Linked to Prostate Cancer Incidence
Testosterone replacement therapy vs placebo was not associated with a higher incidence of prostate cancer among men with hypogonadism.
Stay updated with breaking news from Efficacy Measures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Testosterone replacement therapy vs placebo was not associated with a higher incidence of prostate cancer among men with hypogonadism.
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented three posters at the ERS International Congress 2022 that took place September 4-6th in Barcelona, Spain.Below are summaries of each poster presented:Abstract #2170:...
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented three posters at the ERS International Congress 2022 that took place September
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the acceptance of three abstracts for poster presentation at the ERS International Congress 2022 to be held in-person and virtually, September 4-6, 2022 in Barc...